What Investors Need to Know About the Celgene, Amgen & Bristol-Myers DealsZacks Investment Research • 08/28/19
What Has Led Bristol-Myers Squibb's Stock To Fall More Than 35% Over The Last 3 Years?Forbes • 08/15/19
BMY Stock Plus Celgene Will Be A Top 5 Pharma — But Should You Buy It?Investors Business Daily • 08/08/19
These 5 Prescription Drugs Will Generate a Jaw-Dropping $62.3 Billion in 2024The Motley Fool • 08/04/19